Home / US Department of Health and Human Services / PAR-25-113

Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

Open now · Grant · PAR-25-113

Check my fit, free Open the official call ↗

Next cut-off

07 Sept '27

in 366 days

Call budget

across every grant here

Grants expected

not published for this call

Funding rate

not published, read the conditions

What this call funds

The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.

What applying costs you

Item	Estimate	Note
Drafting effort	3–4 weeks	single submission
Time to first payment	6–9 months	cut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Also open in HHS

CallNext cut-offPer grant

Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)PAR-25-038 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)PAR-25-193 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)PAR-25-066 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)PAR-25-064 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)PAR-25-039 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit